the aid library

LIST OPTIONS

Filter

1357

Sort by:

Direction:

Download (49)

View PDF (100)

Recomendações para o manejo da asma da Sociedade Brasileira de Pneumologia e Tisiologia – 2020

Menezes Pizzichini, M. M.; de Carvalho-Pinto, R. M.; Delfini Cançado, J. E.; et al. (2020) CC2

The pharmacological management of asthma has changed considerably in recent decades, as it has come to be understood that it is a complex, heterogeneous disease with different phenotypes and endotypes. It is now clear that the goal of asthma treatment should be to achieve and maintain control of the... more

Download (107)

View PDF (1378)

Planetary health and the role of community health workers

Manas R. , Behera R., Satpathy S.K. J Family Med Prim Care (2020) C1

In this era, grand challenges lies in biodiversity loss, climate change, and global noncommunicable diseases signify that planet and humanity are in crisis. Scholarly evidence from human and animal kingdom suggest that there is an optimism in planetary health which can provide a unique and novel con... more

Download (130)

View PDF (242)

Trastorno por déficit de atención con hiperactividad

T. S. Moriyama; A. J. M. Cho; R. E. Verin; et al. IACAPAP (2017) C2

Trastornos externalizantes Capítulo D.1 Edición: Matías Irarrázaval & Andrés Martín Traducción: Fernanda Prieto Tagle, Marta García Acuña

Download (203)

View PDF (281)

Transtorno del espectro del autismo

J. Fuentes; M. Bakare; K. Munir; et al. IACAPAP (2017) C2

Trastornos del desarrollo Capítulo C.2 Traducción de la versión inglesa del 2014 Manual de Salud Mental Infantil y Adolescente de la IACAPAP

Download (135)

View PDF (167)

Global child and adolescent mental health: The orphan of development assistance for health

Lu C., Li Z.; Patel V. PLOS Medecine (2018) CC

More than 40% of the world population is 24 years old or younger, the vast majority of whom live in low- and lower middle–income countries. Globally, a quarter of disability-adjusted life years (DALYs) for mental disorders and substance abuse is borne by this age group and about 75% of mental diso... more

Download (325)

View PDF (206)

Nursing Guide for Managing Side Effectsto Drug-resistant TB Treatment

Raftery A, Tudor C, True L, Navarro C (2018) C1

The guide is organized into the major types of toxicities, the associated symp-toms, possible offending medications, and the suggested nursing assessments and interventions. Some symptoms (e.g. nausea) may be associated with a num-ber of underlying causes and may be mild, or a symptom of... more

Download (573)

View PDF (741)

Assessing the efficiency of hospitals in Malawi: An application of the Pabón Lasso technique

E.Z Asbu, O. Walker and J. M Kirigia, et al. World Health Organisation (WHO) (2012) C_WHO

Download (42)

View PDF (46)

Understanding and controlling asthma in Latin America: A review of recent research informed by the SCAALA programme

Cooper, P. J.; Figueiredo, C. A.; Rodriguez, A.; et al. (2023) CC2

Asthma is the most common chronic respiratory disease (CRD) worldwide and is estimated to affect 262 million causing significant mortality and morbidity, and has emerged as an important public health problem in many Latin American (LA) countries over the last 30 or so years. LA is a highly diverse r... more

Download (129)

View PDF (180)

Job satisfaction among healthcare workers in Ghana and Kenya during the COVID-19 pandemic: Role of perceived preparedness, stress, and burnout

Afulani PA, Nutor JJ, Agbadi P, Gyamerah AO, Musana J, Aborigo RA, et al. PLOS Global Public Health (2021) CC

The COVID-19 pandemic has affected job satisfaction among healthcare workers; yet this has not been empirically examined in sub-Saharan Africa (SSA). We addressed this gap by examining job satisfaction and associated factors among healthcare workers in Ghana and Kenya during the COVID-19 pandemic. W... more

Download (116)

View PDF (760)

Clinical and public health implications of acute and early HIV detection and treatment: a scoping review

Rutstein, S.E., J. Ananworanich, S. Fidler, et al. Journal of the International AIDS Society (2017) CC

Rutstein SE et al. Journal of the International AIDS Society 2017, 20:21579 http://www.jiasociety.org/index.php/jias/article/view/21579 | http://dx.doi.org/10.7448/IAS.20.1.21579

Download (122)

View PDF (356)

Financing HIV Programming: How Much Should Low And Middle-Income Countries and their Donors Pay?

Galarraga, O.; V. J. Wirtz; Y. Santa-Ana-Tellez et al. PLOS One (2013) C1

Global HIV control funding falls short of need. To maximize health outcomes, it is critical that national governments sustain reasonable commitments, and that international donor assistance be distributed according to country needs and funding gaps. We develop a country classification framework in t... more

Download (151)

View PDF (1218)

Vitamin D Deficiency and Tuberculosis Progression

N. Talat, S. Perry, J. Personnet, et al. (2010) C_CDC

Emerging Infectious Diseases Vol. 16, No. 5, May 2010

Download (107)

View PDF (591)

The environmental footprint of health care: a global assessment

Lenzen, M.; A. Malik, M.Li, et al. (2020) CC

Lancet Planet Health 2020; 4: e271–79

Download (234)

View PDF (282)

Methadone maintenance treatment and mortality in people with criminal convictions: A population-based retrospective cohort study from Canada

A. Russolillo; A. Moniruzzaman; J. M. Somers PLOS Medicine (2018) CC

Research Article PLOS Medicine | https://doi.org/10.1371/journal.pmed.1002625 July 31, 2018 / 1-19

Download (312)

View PDF (487)

Methods used by WHO to estimate the global burden of TB disease

P. Glaziou, C.Sismanidis, P. J. Dodd, et al. World Health Organization; University of Sheffield (2017) C_WHO

30 October 2017

Download (107)

View PDF (1112)

Achieving UNAIDS 90-90-90 targets for pregnant and postpartum women in sub-Saharan Africa: progress, gaps and research needs

L. L. Abuogi; J. M. Humphrey; C. Mpody, et al. Journal of Virus Eradication (2018) CC

Journal of Virus Eradication 2018; 4 (Supplement 2): 33–39

Download (212)

View PDF (231)

Troubles du spectre autistique

J. Fuentes; M.Bakare; K. Munir; et al. IACAPAP (2012) C2

Troubles du Développement Chapitre C.2

Download (112)

View PDF (517)

The social context of schistosomiasis and its control: an introduction and annotated bibliography

Bruun, B.; Aagaard-Hansen, J.; Watts, S. World Health Organization WHO; Institutional Repository for Information Sharing iris (2008) C_WHO

Schistosomiasis is widely recognized as a disease that is socially determined. An understanding of the social and behavioural factors linked to disease transmission and control should play a vital role in designing policies and strategies for schistosomiasis prevention and control. To this must b... more

Download (117)

View PDF (331)

The social context of schistosomiasis and its control

Brunn, B.; Aagaard-Hansen, J.; Watts, S. World Health Organization WHO (2008) C_WHO

Download (150)

View PDF (194)

Government policy interventions to reduce human antimicrobial use: A systematic review and evidence map

Van Katwyk, S. R.; Grimshaw, J. M.; et al (2019) C2

BACKGROUND: Growing political attention to antimicrobial resistance (AMR) offers a rare opportunity for achieving meaningful action. Many governments have developed national AMR action plans, but most have not yet implemented policy interventions to reduce antimicrobial overuse. A systematic evidenc...e map can support governments in making evidence-informed decisions about implementing programs to reduce AMR, by identifying, describing, and assessing the full range of evaluated government policy options to reduce antimicrobial use in humans. METHODS AND FINDINGS: Seven databases were searched from inception to January 28, 2019, (MEDLINE, CINAHL, EMBASE, PAIS Index, Cochrane Central Register of Controlled Trials, Web of Science, and PubMed). We identified studies that (1) clearly described a government policy intervention aimed at reducing human antimicrobial use, and (2) applied a quantitative design to measure the impact. We found 69 unique evaluations of government policy interventions carried out across 4 of the 6 WHO regions. These evaluations included randomized controlled trials (n = 4), non-randomized controlled trials (n = 3), controlled before-and-after designs (n = 7), interrupted time series designs (n = 25), uncontrolled before-and-after designs (n = 18), descriptive designs (n = 10), and cohort designs (n = 2). From these we identified 17 unique policy options for governments to reduce the human use of antimicrobials. Many studies evaluated public awareness campaigns (n = 17) and antimicrobial guidelines (n = 13); however, others offered different policy options such as professional regulation, restricted reimbursement, pay for performance, and prescription requirements. Identifying these policies can inform the development of future policies and evaluations in different contexts and health systems. Limitations of our study include the possible omission of unpublished initiatives, and that policies not evaluated with respect to antimicrobial use have not been captured in this review. CONCLUSIONS: To our knowledge this is the first study to provide policy makers with synthesized evidence on specific government policy interventions addressing AMR. In the future, governments should ensure that AMR policy interventions are evaluated using rigorous study designs and that study results are published. more